Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and effectiveness of daily
dextromethorphan/quinidine (Nuedexta) in reducing the frequency and progression of episodic
migraine.